Dense Electrode Layers-Supported Microtubular Oxygen Pump.

An oxygen pump is an electrochemical device that extracts oxygen from the air and has the potential to be used in medicine. The development and test results of a microtubular solid oxide oxygen pump with Ce0.76Gd0.24O2-δ (GDC) electrolyte are presented. The supporting components of the oxygen pump are symmetrical dense electrode layers made of the La0.8Sr0.2Co0.2Fe0.8O3-δ (LSCF)-GDC composite. Studies carried out by impedance spectroscopy on planar samples showed that the polarization resistance of the dense electrodes was greatly lower (by 2.5-5 times) than that of standard porous LSCF electrodes. Microtubular oxygen pumps were fabricated by the isostatic pressing of a stack of tapes rolled into a tube and subsequent co-sintering. The use of a nanosized GDC powder as the initial material for the tapes allowed their co-sintering at 1200 °C. In such a way, the chemical interaction between GDC and LSCF was prevented. Samples of the prepared cells had an outer diameter of 1.9 and 3.5 mm, and the thickness of the electrolyte and of the dense supporting electrodes was 20 and 130 µm, respectively. The specific oxygen productivity of the cells was 0.29 L∙h-1∙cm-2 at 800 °C and a current density of 1.26 A·cm-2 (0.53 V). Thus, the energy consumption with the developed design for the production of 1 L of oxygen was 2.3 W∙h. The microtubular oxygen pumps appeared highly resistant to thermal shock.

Classification of Solid Oxide Fuel Cells.

Solid oxide fuel cells (SOFC) are promising, environmentally friendly energy sources. Many works are devoted to the study of materials, individual aspects of SOFC operation, and the development of devices based on them. However, there is no work covering the entire spectrum of SOFC concepts and designs. In the present review, an attempt is made to collect and structure all types of SOFC that exist today. Structural features of each type of SOFC have been described, and their advantages and disadvantages have been identified. A comparison of the designs showed that among the well-studied dual-chamber SOFC with oxygen-ion conducting electrolyte, the anode-supported design is the most suitable for operation at temperatures below 800 °C. Other SOFC types that are promising for low-temperature operation are SOFC with proton-conducting electrolyte and electrolyte-free fuel cells. However, these recently developed technologies are still far from commercialization and require further research and development.

Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial.

BACKGROUND: Non-immunogenic staphylokinase is modified recombinant staphylokinase with low immunogenicity, high thrombolytic activity, and selectivity to fibrin. We aimed to assess the safety and efficacy of a single intravenous bolus of non-immunogenic staphylokinase compared with alteplase in patients with acute ischaemic stroke within 4·5 h after symptom onset. METHODS: We did a randomised, open-label, multicentre, parallel-group, non-inferiority trial in 18 clinical sites in Russia. We included patients aged 18 years and older with a diagnosis of acute ischaemic stroke (up to 25 points on the National Institutes of Health Stroke Scale). The study drug had to be administered within 4·5 h after the onset of symptoms. Patients were randomly assigned to receive either non-immunogenic staphylokinase (10 mg) or alteplase (0·9 mg/kg, maximum 90 mg), both administered intravenously. The randomisation sequence was created by an independent biostatistician using computer-generated random numbers. 84 blocks (block size of four) of opaque sealed envelopes were numbered sequentially from 1 to 336 and were opened in numerical order. Patients were unaware of their assigned treatment and were assessed by the study investigators who were also unaware of the treatment assignment on all trial days. Emergency department staff, who administered the assigned drug and opened the envelopes, were not masked to treatment. The primary efficacy endpoint was a favourable outcome, defined as a modified Rankin scale (mRS) score of 0-1 on day 90. The margin of non-inferiority was established as 16% for the difference in mRS score of 0-1 on day 90. Non-inferiority was tested using Welch's t-test for the primary outcome only. Endpoints were analysed in the per-protocol population, which comprised all randomly assigned patients who completed treatment without any protocol violations; this population was identical to the intention-to-treat population. This trial is completed and registered at ClinicalTrials.gov, NCT03151993. FINDINGS: Of 385 patients recruited from March 18, 2017, to March 23, 2019, 336 (87%) were included in the trial. 168 (50%) patients were randomly assigned to receive non-immunogenic staphylokinase and 168 (50%) to receive alteplase. The median duration of follow-up was 89 days (IQR 89-89). 84 (50%) of 168 patients in the non-immunogenic staphylokinase group had a favourable outcome at day 90 compared with 68 (40%) of 168 patients in the alteplase group (odds ratio [OR] 1·47, 95% CI 0·93 to 2·32; p=0·10). The difference in the rate of favourable outcome at day 90 was 9·5% (95% CI -1·7 to 20·7) and the lower limit did not cross the margin of non-inferiority (pnon-inferiority <0·0001). Symptomatic intracranial haemorrhage occurred in five (3%) patients in the non-immunogenic staphylokinase group and in 13 (8%) patients in the alteplase group (p=0·087). On day 90, 17 (10%) patients in the non-immunogenic staphylokinase group and 24 (14%) patients in the alteplase group had died (p=0·32). 22 (13%) patients in the non-immunogenic staphylokinase group had serious adverse events, compared with 37 (22%) patients in the alteplase group (p=0·044). INTERPRETATION: Non-immunogenic staphylokinase was non-inferior to alteplase for patients with acute ischaemic stroke. Mortality, symptomatic intracranial haemorrhage, and serious adverse events did not differ significantly between groups. Future studies are needed to continue to assess the safety and efficacy of non-immunogenic staphylokinase in patients with acute ischaemic stroke within the 4·5 h time window, and to assess the drug in patients with acute ischaemic stroke outside this time window with reperfusion CT or magnetic resonance angiography followed by thrombectomy if necessary. FUNDING: The Russian Academy of Sciences.

Synthesis of Lithium Phosphorus Oxynitride (LiPON) Thin Films by Li3PO4 Anodic Evaporation in Nitrogen Plasma of a Low-Pressure Arc Discharge.

Thin amorphous films of LiPON solid electrolyte were prepared by anodic evaporation of lithium orthophosphate Li3PO4 in an arc discharge with a self-heating hollow cathode at a nitrogen pressure of 1 Pa. Distribution of the arc current between two electrodes having an anode potential provided independent control of the evaporation rate of Li3PO4 and the density of nitrogen plasma. Stabilization of the evaporation rate was achieved using a crucible with multi-aperture cover having floating potential. The existence of a threshold value of discharge current (40 A) has been established, which, upon reaching ionic conductivity over 10-8 S/cm, appears in the films. Probe diagnostics of discharge plasma were carried out. It has been shown that heating the films during deposition by plasma radiation to a temperature of 200 °C is not an impediment to achieving high ionic conductivity of the films. Dense uniform films of LiPON thickness 1 µm with ionic conductivity up to 1 × 10-6 S/cm at a deposition rate of 4 nm/min are obtained.

The grain size effect on the yttria stabilized zirconia grain boundary conductivity.

Conductivity of yttria stabilized zirconia produced from weakly agglomerated nanopowder was investigated by ac impedance spectroscopy. Dense ceramic samples with the grain size from 90 to 800 nm were prepared at the variation of both pressing and sintering conditions. It was found that the bulk conductivity is not affected by grain size, while grain boundary conductivity is dependent on this factor. Observed grain boundary resistance increases with grain size. This relationship is contrary to the previous results obtained for the range from 1 to 18 microm where grain boundary resistance decreased with grain size. Maximum of grain boundary resistance versus ceramics grain size is observed at 450 degrees C for the grain size about 270 nm.